Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.18 EPS for the quarter, Zacks reports.
Fresenius SE & Co. KGaA Stock Up 4.8 %
Shares of OTCMKTS FSNUY opened at $10.15 on Thursday. The company has a debt-to-equity ratio of 0.57, a quick ratio of 1.05 and a current ratio of 1.36. Fresenius SE & Co. KGaA has a 12 month low of $6.57 and a 12 month high of $10.42. The company has a 50 day simple moving average of $9.33 and a two-hundred day simple moving average of $9.19.
Wall Street Analyst Weigh In
Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Fresenius SE & Co. KGaA in a research note on Monday, February 3rd.
Fresenius SE & Co. KGaA Company Profile
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Featured Articles
- Five stocks we like better than Fresenius SE & Co. KGaA
- How to Profit From Value Investing
- 2 Stocks Riding the Dominance of America’s Natural Gas Exports
- Following Congress Stock Trades
- Buffett’s on the Sidelines – Should You Follow?
- The Basics of Support and Resistance
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
